Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
54.62
+0.21 (0.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Agios Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for AGIO stock have an average target of 52.33, with a low estimate of 46 and a high estimate of 56. The average target predicts a decrease of -4.19% from the current stock price of 54.62.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AGIO stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 2 | 2 | 4 | 4 |
| Hold | 2 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 5 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $55 | Buy | Reiterates | $55 | +0.70% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $51 → $53 | Buy | Maintains | $51 → $53 | -2.97% | Nov 1, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $51 | Buy | Initiates | $51 | -6.63% | Oct 16, 2024 |
| Raymond James | Raymond James | Buy Initiates $51 | Buy | Initiates | $51 | -6.63% | Oct 10, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $60 → $56 | Buy → Hold | Downgrades | $60 → $56 | +2.53% | Sep 27, 2024 |
Financial Forecast
Revenue This Year
35.78M
from 26.82M
Increased by 33.38%
Revenue Next Year
94.11M
from 35.78M
Increased by 163.06%
EPS This Year
11.71
from -6.33
EPS Next Year
-6.20
from 11.71
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 38.5M | 281.1M | 238.7M | ||
| Avg | 35.8M | 94.1M | 175.4M | ||
| Low | 33.3M | 51.0M | 132.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 43.7% | 685.7% | 153.6% | ||
| Avg | 33.4% | 163.1% | 86.3% | ||
| Low | 24.2% | 42.4% | 40.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.44 | -3.38 | -3.42 | ||
| Avg | 11.71 | -6.20 | -5.35 | ||
| Low | 10.27 | -7.06 | -7.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.